Package 0078-0337-06

{"route": ["ORAL"], "spl_id": "dcd739ce-e938-40e6-8912-ca4f34b49cf3", "openfda": {"nui": ["N0000175753", "N0000008486"], "unii": ["VZI5B1W380"], "rxcui": ["261356", "261360", "262090", "283536", "312136", "312137", "312138", "351992"], "spl_set_id": ["4c5c86c8-ab7f-4fcf-bc1b-5a0b1fd0691b"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["Novartis Pharmaceuticals Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED in 1 BOTTLE (0078-0337-05)", "package_ndc": "0078-0337-05", "marketing_start_date": "20000130"}, {"sample": false, "description": "100 BLISTER PACK in 1 BOX, UNIT-DOSE (0078-0337-06)  / 1 TABLET, FILM COATED in 1 BLISTER PACK (0078-0337-61)", "package_ndc": "0078-0337-06", "marketing_start_date": "20000130"}], "brand_name": "Trileptal", "product_id": "0078-0337_dcd739ce-e938-40e6-8912-ca4f34b49cf3", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "0078-0337", "generic_name": "oxcarbazepine", "labeler_name": "Novartis Pharmaceuticals Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Trileptal", "active_ingredients": [{"name": "OXCARBAZEPINE", "strength": "300 mg/1"}], "application_number": "NDA021014", "marketing_category": "NDA", "marketing_start_date": "20000130", "listing_expiration_date": "20261231"}